pharmaphorum

SEPTEMBER 30, 2022

Merck & Co has been fighting to defend its blockbuster type 2 diabetes therapy Januvia from generic competition for years, and a new judgment looks set to protect its third biggest-selling drug for another few years. 8,414,921), which covers the co-formulation of sitagliptin and metformin and is due to expire in 2029.

Marketing 59

Marketing Sales Competition FDA 59

Pharmaceutical Technology

JANUARY 10, 2023

Type 2 diabetes (T2D) is a crowded and competitive landscape with multiple “me-too,” generic and biosimilar drugs entering the market, with market growth primarily driven by an increasing prevalent population across nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, China, and India).

Marketing 52

Marketing Physicians Leads Sales 52

Pharmaceutical Technology

MAY 16, 2023

million by 2029. Although Sanofi may face generic drug competition this year for its multiple sclerosis drug, Aubagio, the company is expected to maintain their sales of Dupixent, accounting for 43.3% Sanofi and Regeneron’s market capitalisation grew by 12.4%

Marketing 52

Marketing Sales Pharma Leads 52

PM360

SEPTEMBER 21, 2023

Attention deficit hyperactivity disorder (ADHD) drug Vyvanse (lisdexamfetamine dimesylate) , manufactured by Takeda, also is facing generic competition. In the respiratory area with inhalers, it’s tough to get drugs approved, so the competition comes slowly,” he said. Starting in 2026, the provision will affect 10 Part D drugs.

Management 105

Management Manufacturing Sales Competition 105

pharmaphorum

NOVEMBER 24, 2022

Analysts at GlobalData have previously forecast that Spravato will generate global sales of approximately $383 million by 2029, with its potential pegged back by its cost and a requirement for two hours of patient observation after administration.

Sales 52

Sales Patients Competition Marketing 52

Medico Reach

OCTOBER 17, 2022

billion by 2029. The potential increase in industry competition could also spell trouble for some. However, current orthopedic medical device trends all point towards the increasing use of such systems. In fact, the market size for orthopedic surgical robots will reach roughly $24.2

Medical 98

Medical Food and Drug Administration Healthcare Healthcare 98

Quantified

SEPTEMBER 21, 2023

through 2029. Competitive pressure will drive companies to invest in AI tools for sales. Making a prospect wait hours for a response will become a competitive disadvantage. Presenting an Offer In a competitive sales environment, a sales team may have 30 minutes on a Zoom call to review an offer.

Sales 52

Sales Prospecting Training Sales tools 52

Medico Reach

OCTOBER 17, 2022

billion by 2029. The potential increase in industry competition could also spell trouble for some. However, current orthopedic medical device trends all point towards the increasing use of such systems. In fact, the market size for orthopedic surgical robots will reach roughly $24.2

Medical 52

Medical Food and Drug Administration Healthcare Healthcare 52

Spotio

MAY 7, 2024

billion in the US alone by 2029. Craft Your Unique Value Proposition Why should prospects buy from your company , not the competition? There’s never been a better time to be in telecom sales. The industry is expected to grow to 530.61 More interest in your telecom services, shorter sales cycles, and ultimately, more sales.

Leads 52

Leads Sales Prospecting Distribution 52

Pharmaceutical Technology

MAY 17, 2023

billion in 2029. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. The condition gradually worsens and can result in liver failure.

Food and Drug Administration 52

Food and Drug Administration FDA Pharmaceutical Prospecting 52

Clarivate

OCTOBER 17, 2024

As California Attorney General from 2011 to 2017, Harris was a forceful opponent of healthcare industry consolidation, both vertical and horizontal, believing that mergers of hospitals, physician groups and insurers would damage competition and raise prices for care.

Healthcare 52

Healthcare Healthcare Government Insurance 52